Indo US Bio-Tech Ltd

Indo US Bio-Tech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Indo US Bio-Tech Ltd

₹ 168 0.42%
11 Jun - close price
indousagriseeds.com BSE: 541304 NSE: INDOUS
About

Incorporated in 2004, Indo US Bio-Tech Ltd is engaged in production and processing of commercial and vegetable seeds[1]

Key Points

Business Overview:[1]
IUBTL is involved in crop Research and Development through breeding, seed production, processing, packing, and marketing of hybrid and open pollinated varieties of agricultural crops

Website BSE NSE
  • Market Cap ₹ 343 Cr.
  • Current Price ₹ 168
  • High / Low ₹ 388 / 138
  • Stock P/E 21.1
  • Book Value ₹ 39.2
  • Dividend Yield 0.15 %
  • ROCE 21.2 %
  • ROE 23.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter
  • Company has delivered good profit growth of 45.0% CAGR over last 5 years
  • Debtor days have improved from 98.2 to 52.7 days.
  • Company's median sales growth is 20.2% of last 10 years

Cons

  • Tax rate seems low

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Fast Moving Consumer Goods Fast Moving Consumer Goods Agricultural Food & other Products Other Agricultural Products

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
14.38 13.75 15.50 18.11 19.14 15.81 22.11 15.77 24.72 22.17 23.56 33.38
12.14 11.77 13.44 15.02 16.15 13.21 17.88 14.79 21.03 17.05 18.02 28.80
Operating Profit 2.24 1.98 2.06 3.09 2.99 2.60 4.23 0.98 3.69 5.12 5.54 4.58
OPM % 15.58% 14.40% 13.29% 17.06% 15.62% 16.45% 19.13% 6.21% 14.93% 23.09% 23.51% 13.72%
0.00 0.00 0.00 0.02 0.03 0.00 0.08 0.21 0.03 0.02 0.02 0.12
Interest 0.28 0.22 0.41 0.27 0.37 0.41 0.37 0.36 0.33 0.52 0.38 0.26
Depreciation 0.16 0.17 0.29 0.21 0.20 0.21 0.19 0.20 0.20 0.18 0.16 0.56
Profit before tax 1.80 1.59 1.36 2.63 2.45 1.98 3.75 0.63 3.19 4.44 5.02 3.88
Tax % 0.00% 18.87% -1.47% -5.32% 3.27% 15.66% 1.87% 17.46% 0.63% 2.03% -0.80% 4.90%
1.80 1.30 1.37 2.77 2.37 1.67 3.68 0.52 3.17 4.36 5.05 3.68
EPS in Rs 0.98 0.65 0.68 1.38 1.18 0.83 1.84 0.26 1.58 2.17 2.52 1.84
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
15 20 19 24 29 35 40 39 49 62 73 104
14 19 19 23 27 32 36 34 42 52 62 85
Operating Profit 0 1 0 1 3 3 4 6 7 9 11 19
OPM % 3% 3% 3% 5% 9% 10% 10% 14% 14% 15% 15% 18%
0 0 0 0 0 0 -0 0 0 0 0 0
Interest 0 0 0 1 1 0 1 1 1 1 2 1
Depreciation 0 0 0 0 0 0 0 0 0 1 1 1
Profit before tax 0 0 0 1 2 3 3 4 5 7 9 17
Tax % -136% -92% -50% 25% 29% 26% 12% -23% 5% 2% 6% 2%
0 0 0 0 1 2 3 5 5 7 8 16
EPS in Rs 0.72 1.11 0.80 0.89 1.41 1.44 1.74 3.52 2.86 3.60 4.11 8.11
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 18%
5 Years: 21%
3 Years: 28%
TTM: 43%
Compounded Profit Growth
10 Years: 42%
5 Years: 45%
3 Years: 46%
TTM: 97%
Stock Price CAGR
10 Years: %
5 Years: 52%
3 Years: 82%
1 Year: -21%
Return on Equity
10 Years: 19%
5 Years: 19%
3 Years: 18%
Last Year: 23%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 1 1 1 1 3 5 6 6 9 10 20 20
Reserves 1 1 2 2 2 9 10 15 30 44 43 58
2 2 5 5 7 6 9 11 12 12 14 15
2 3 6 4 6 4 10 11 4 3 7 4
Total Liabilities 6 8 14 13 17 24 35 44 56 69 84 98
1 1 1 1 2 1 1 2 6 7 7 10
CWIP 0 0 0 0 0 1 1 2 2 1 4 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
5 7 13 11 16 21 32 39 48 61 74 88
Total Assets 6 8 14 13 17 24 35 44 56 69 84 98

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0 -1 -3 -1 0 3 1 -5 1
-0 0 -3 -1 -2 -5 -7 4 -1
0 1 6 2 1 2 6 1 -1
Net Cash Flow -0 0 0 0 -0 -0 0 1 -1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 49 25 107 76 112 94 193 229 152 146 95 53
Inventory Days 64 91 118 92 98 176 751
Days Payable 51 57 115 64 71 34 667
Cash Conversion Cycle 62 59 110 104 138 236 276 229 152 146 95 53
Working Capital Days 75 66 118 100 120 178 202 261 325 339 331 288
ROCE % 9% 14% 7% 14% 28% 20% 17% 18% 16% 15% 14% 21%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
73.01% 74.02% 70.17% 70.17% 70.17% 70.17% 70.17% 70.18% 70.18% 70.18% 70.18% 70.18%
26.98% 25.98% 29.83% 29.83% 29.83% 29.83% 29.83% 29.83% 29.82% 29.83% 29.82% 29.83%
No. of Shareholders 2552332592352513181,2271,1661,1339712,8282,780

Documents

Announcements

Annual reports

DRHP